Calcipotriene for Psoriasis Treatment

Mechanism of Action

• Calcipotriene works by binding to vitamin D receptors, which helps normalize the accelerated cell turnover seen in psoriasis 1, 2

Clinical Efficacy

• Calcipotriene has demonstrated significant efficacy in treating psoriasis, with 65-70% of patients experiencing marked improvement or clearing 2
• For scalp psoriasis, calcipotriene foam was more effective than vehicle in achieving clear or almost clear status (40.9% vs 24.2%) after 8 weeks 4

Combination Therapy

• The American Academy of Dermatology recommends adding calcipotriene to standard dose methotrexate therapy for treating moderate to severe psoriasis 5
• Combination with betamethasone dipropionate has shown enhanced efficacy compared to either agent alone 1, 4

Treatment Recommendations

• The American Academy of Dermatology-National Psoriasis Foundation guidelines support long-term use of topical vitamin D analogues (including calcipotriene) for up to 52 weeks for treating mild to moderate psoriasis 3

Safety Considerations and Precautions

• Calcipotriene should be used with caution in patients with disorders of calcium metabolism or renal disease 2, 3
• No serious adverse events, including striae or hypothalamic-pituitary-adrenal axis suppression, were observed over 52-week treatment periods with calcipotriene 0.005% and betamethasone 0.064% 4

Important Caveats and Interactions

• Simultaneous use of salicylic acid with calcipotriene should be avoided because the acid pH will inactivate calcipotriene and reduce its effectiveness 3, 6
• UVA radiation can decrease the concentration of calcipotriene on the skin; if used with phototherapy, calcipotriene should be applied after the treatment 3, 4